Metro bus project inches towards materialisation
The Metro Bus Service, a mega project under the Bus Rapid Transit (BRT) system, is progressing in Faisalabad to provide modern, efficient, and dignified urban transport.
A team from the Punjab Transport Department, led by Punjab Mass Transit Authority (PMTA) Managing Director Kunwar Anwar Ali Khan, visited Faisalabad and met with Director General Faisalabad Development Authority (FDA) Muhammad Asif Chaudhry to discuss the project's development.
The visiting delegation included General Manager Operations PMTA Usman Shah, Manager Operations Rizwan Aziz, Senior Engineers from NESPAK Musa Dar, Sameed Anis, Ubaidullah, and Project Manager Jamshed Faisal.
They were welcomed by FDA Additional Director General Yasser Ejaz Chatha, Chief Engineer Mehr Ayub, Deputy Director Engineering Omar Iqbal, and other officials.
During the meeting, Director General FDA Muhammad Asif Chaudhry emphasized that the FDA had provided full administrative support during the project's feasibility study conducted by the Asian Development Bank (ADB).
He stated that multiple routes have been proposed for the Metro Bus Service, with consultations held with stakeholders to ensure a strategic and well-integrated urban transport system for Faisalabad. Managing Director PMTA Kunwar Anwar Ali Khan reviewed the proposed metro routes from a technical and technological perspective.
He confirmed that NESPAK engineers are preparing a detailed report to assess the feasibility of the routes. He also announced that the Punjab Secretary of Transport will soon visit Faisalabad to further inspect the proposed routes and coordinate planning with the district administration.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Express Tribune
02-06-2025
- Express Tribune
Sanofi's $9.5B acquisition of Blueprint Medicines strengthens rare immunology portfolio
In a major move underscoring its ambition to lead in rare diseases and immunology, French pharmaceutical giant Sanofi announced its plan to acquire US-based Blueprint Medicines for up to $9.5 billion. The deal was announced by a press release on Sanofi's website. It is the largest by a European healthcare company this year and will see Sanofi paying $129 per share in cash, a significant premium that sent Blueprint's stock soaring in premarket trading. Blueprint Medicines, known for its specialty in treating systemic mastocytosis a rare blood disorder marked by the overproduction of mast cells brings to Sanofi a strong foothold in a niche yet critical area of medicine. The acquisition adds the FDA-approved drug Ayvakit, the only treatment for advanced systemic mastocytosis, to Sanofi's growing immunology portfolio. Sanofi CEO Paul Hudson framed the deal as a strategic leap forward, enhancing the company's pipeline and reinforcing its transformation into a global leader in immunology. We announced an agreement to acquire Blueprint Medicines, a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, and other KIT-driven diseases. — Sanofi (@sanofi) June 2, 2025 With a promising pipeline including next-generation therapies like elenestinib and BLU-808, the acquisition fits into Sanofi's broader ambition of innovation despite recent setbacks, including a failed lung disease drug trial. Industry analysts from JP Morgan praised the acquisition for its strategic and financial merits, forecasting Ayvakit could generate $2 billion in annual sales by 2030. Sanofi's ongoing spree of acquisitions, including Vigil Neuroscience and Inhibrx, signals a company doubling down on R&D investments to reshape its future. The acquisition aligns with Sanofi's broader strategy to invest heavily in US manufacturing and research, tapping into incentives and momentum driven by recent government policies. With Blueprint Medicines now joining its portfolio, Sanofi cements its stake in cutting-edge immunology treatments and rare disease therapies, positioning itself for long-term growth in a competitive pharmaceutical landscape.
Business Recorder
03-05-2025
- Business Recorder
Senior Management Course at NIPA Peshawar: Officers briefed about FDA urban development
FAISALABAD: An 18-member group of officers participating in the 37th Senior Management Course at the National Institute of Public Administration (NIPA) Peshawar visited the FDA Complex on a study tour. Director General FDA Muhammad Asif Chaudhry, Additional Director General Kaiser Abbas Rind and other officers welcomed the guests, who were led by Chief Instructor Tariq Bakhtiar. Later, the group of officers attended a briefing session. Director General FDA Muhammad Asif Chaudhry welcomed the visiting officers and briefed them about the organisational structure, jurisdiction, legal framework, performance, development activities and other matters of urban development of the Faisalabad Development Authority. He said that the process of complete digitization of records is being completed to enhance the quality of FDA services, provision of speedy relief and keeping transparency in office matters, due to which various services are being provided online, including issuance of Ownership Clearance Certificate on the spot, e-challan system and other services. He said that several urban development projects are in the credit of FDA, while recently the mega projects of Abdullah Jhumra Road Flyover and state-of-the-art sports complex in FDA City have been completed. He informed about various measures regarding the rapid development of FDA City and said that there is a strong infrastructure to provide all the basic facilities of excellent quality, while the project of beautification and development of Central Park on an area of 82 kanals equipped with a beautiful lake, Miyawaki Forest and other recreational facilities is underway. The DG FDA said that the property management and administration of 17 residential colonies, 18 commercial markets and 111 katchi abadies are under the control of the FDA. He said that the operation against illegal housing schemes is continuing regularly and information about such schemes is being uploaded on the website for public awareness. Copyright Business Recorder, 2025
Express Tribune
24-03-2025
- Express Tribune
E-buses allocated for urban transport
A large number of citizens travelled on the Green Line buses from morning till night. PHOTO: EXPRESS The Punjab government has allocated 86 electric buses for Faisalabad Urban Transport, aiming to provide quality public transport services in the city. As part of this initiative, 33 buses are expected to be delivered soon and will operate on six different routes. This project is separate from the planned metro bus service for the city. Faisalabad Development Authority (FDA) Director General Muhammad Asif Chaudhry, shared these developments while addressing representatives from the business community and real estate sector at the Faisalabad Chamber of Commerce and Industry. He highlighted FDA's ongoing projects, jurisdiction, and civic issues impacting the city. Chaudhry informed attendees that while the Faisalabad Master Plan case is currently under court proceedings, the Peri-Urban Structure Plan is being implemented. Under this plan, the city has been zoned to regulate urban development, and environmental impact assessments have been made mandatory for new constructions and housing colonies. The zoning initiative has successfully reduced brownfield areas by 30,000 acres. Additionally, outline development plans for 125 cities, including Faisalabad, have been prepared at the provincial level. Clarifying FDA's role, Chaudhry stated that the authority is responsible for executing development schemes under the deposit work mechanism before handing them over to the Municipal Corporation or other relevant bodies. However, maintenance and repair of these projects do not fall under FDA's jurisdiction. He also discussed major infrastructure projects, including the expansion and reconstruction of key city roads. Notably, Sheikhupura Road, from Nishatabad Bridge to Gatwala, is set to be developed into a state-of-the-art two-way highway featuring rainwater drainage systems and footpaths. Providing an update on FDA City's progress, Chaudhry revealed that 14 out of 18 electricity feeders have been completed. The construction of the DPS campus building is also underway. Additionally, the Central Park project within FDA City will include a scenic lake, the Mianwali Forest, and various recreational facilities. On the topic of urban planning, he detailed the ongoing digitization of FDA records and the Punjab government's efforts to establish a legal framework for regularizing old, unapproved housing schemes. During the session, Faisalabad Chamber of Commerce and Industry (FCCI) President Rehan Nasim Bharara welcomed Chaudhry and raised concerns about civic challenges in the city. He emphasised the urgent need for increased financial resources to address these issues effectively. In conclusion, FCCI Senior Vice President Qaiser Shamshad Gachha extended his gratitude to the guests, while President Bharara presented a shield to Chaudhry as part of the chamber's Golden Jubilee celebrations.
